You're signed outSign in or to get full access.
Takeda Pharmaceutical Co. LTD
Takeda Pharmaceutical Company Limited is a major Japanese multinational pharmaceutical firm headquartered in Tokyo, with significant presence in Osaka and a global footprint spanning over 70 countries. Founded in 1781, Takeda is Asia's third largest pharmaceutical company and ranks among the world's largest by revenue. The company specializes in research, development, manufacturing, sales, and marketing of pharmaceutical drugs, with consolidated employee count exceeding 49,000 as of 2023. Takeda serves healthcare providers and patients worldwide, focusing on life-transforming treatments and global health outcomes.
Investment Strategy
Takeda Pharmaceutical pursues a purpose-led and values-based growth strategy focused on discovering and delivering transformative treatments in oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. The company emphasizes innovation through internal R&D and strategic mergers and acquisitions, aiming for long-term value creation for stakeholders while maintaining a patient-centric approach and strong commitment to its employees and the wider global community.
Latest 13F Filing Activity
Takeda Pharmaceutical Co. LTD filed their most recent 13F report on Jun 30, 2025 disclosing 11 equity positions with a total 13F market value of $20M. The fund increased holdings in Hillevax, Inc., Ovid Therapeutics, Inc., American Well Corporation among other positions. Takeda Pharmaceutical Co. LTD reduced exposure to Rani Therapeutics Holdings, Inc., Equillium, Inc., Shattuck Labs, Inc. among others.
Top Holdings
Equity Positions (11)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
H HLVX | HilleVax, Inc. | 68.43% | $13.4M | 6,724,000 | $16.05 | $1.99 | +$3.6M |
O OVID | Ovid Therapeutics, Inc. | 12.71% | $2.5M | 7,531,996 | $3.22 | $0.33 | +$135.6K |
X XLO | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | 5.13% | $1.0M | 1,475,121 | $0.55 | $0.68 | -$65.1K |
A AMWL | American Well Corporation | 3.53% | $691.0K | 77,733 | $1.49 | $8.89 | +$78.5K |
E EQ | Equillium, Inc. | 2.94% | $575.2K | 1,824,977 | $0.72 | $0.32 | -$136.5K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more